Last reviewed · How we verify

NCT04160806: PDStim

The Effect Of Transcranial Direct Current Stimulation In Panic Disorder

Completed NA Last updated 4 October 2022
What this trial tests

NA trial testing Transcranial direct current stimulation in Panic Disorder in 30 participants. Completed in 1 November 2021.

Timeline
1 November 2019
Primary endpoint
1 November 2021
1 November 2021

Quick facts

Lead sponsorIstanbul University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment30
Start date1 November 2019
Primary completion1 November 2021
Estimated completion1 November 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University

Who can join

Adults 18 to 60, any sex, with Panic Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the present study is to investigate the effect of prefrontal transcranial Direct Current Stimulation (tDCS) on clinical severity, attentional bias and interoceptive accuracy in panic disorder (PD). The participants will be assigned to active and sham groups (1:1) and will receive 10 sessions of tDCS. The study will also examine if the effects may last for a month.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Transcranial direct current stimulation

Trials testing the same drug.

Other recruiting trials for Panic Disorder

Currently open trials in the same condition.

Other Istanbul University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04160806.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing